A pilot study of disease related education and psychotherapeutic support for unresolved grief in parents of children with CF

Author:

Schultz André,Barrett Andrea,Balding Elizabeth,Billingham Wesley,Branch-Smith Cindy,Grover Zubin,Yikilmaz Gisele,Bourke Crystal,Depiazzi Julie,Sander Nicole,Foster Juliet,Cooper Matthew,Zepf Florian

Abstract

AbstractDiagnosis of chronic disease in a child can result in unresolved grief (UG) in parents. This study aimed to evaluate the efficacy of psychological insight-oriented therapy (IOT) as a treatment for UG compared to disease related education in parents of children with cystic fibrosis (CF). Sequence of delivery, first IOT then disease related education (or vice versa) was also examined, to let all participants experience both interventions. Parents were screened for UG. Parents with UG were randomised to either five 1-h sessions of IOT or five 1-h sessions of education. Measures were assessed pre-intervention, after the first intervention period (primary efficacy assessment), and after the second intervention period (swapping intervention). Forty-seven parents were screened of which 46.8% (22/47) had UG. Median duration of UG was 5 years (range: 6 months–14 years). Anxiety (50% vs. 20%, p = 0.03) and stress (59% vs. 28%, p = 0.03) were significantly more prevalent in parents with UG. There was no difference between arms in the odds of UG resolving either following the first intervention period (OR 0.88; 95% CI 0.5, 1.5) or the second intervention period (OR 0.91; 95% CI 0.5, 1.6). While not statistically significant, adjusted mean values for seven of the eight mental health measures were lower in the IOT (first) arm compared to the ED (first) arm, following the first intervention period. UG is a significant burden for families affected by CF. Provision of disease related education and psychological support, regardless of sequence, can result in resolution of grief.Trial registration number: ACTRN12621000796886, date of registration 24/06/2021, retrospectively registered.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference25 articles.

1. 12018. Cystic Fibrosis Foundation [U.S.] Patient registry. https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2018-Patient-Registry-Annual-Data-Report.pdf. (Accessed 1 April 2020).

2. Farrell, P. M. The prevalence of cystic fibrosis in the European Union. J. Cyst. Fibros. 7, 450–453 (2008).

3. Breuer, O. et al. Changing prevalence of lower airway infections in young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 200, 590–599 (2019).

4. Ernst, M. M., Johnson, M. C. & Stark, L. J. Developmental and psychosocial issues in cystic fibrosis. Pediatr. Clin. N. Am. 58(865–85), x (2011).

5. Jedlicka-Kohler, I., Gotz, M. & Eichler, I. Parents’ recollection of the initial communication of the diagnosis of cystic fibrosis. Pediatrics 97, 204–209 (1996).

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3